Stay updated with breaking news from Optimind Pharma Corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Psychedelics therapy provider Optimind Pharma Corp. entered into an acquisition agreement with Wolf Acquisitions 1.0 Corp., an arm's length private British Columbia corporation with investments in the psychedelics industry and one of its wholly-owned subsidiaries.
TORONTO, Oct. 12, 2023 -- Optimind Pharma Corp. is pleased to announce that it has entered into an acquisition agreement dated October 12, 2023 with Wolf Acquisitions 1.0 Corp. , an arm's length...
Optimind looks to accelerate the adoption of the MindSetting TRIP Protocol for ketamine-assisted therapy and other psychedelic enhanced psychotherapy modalities. Toronto, Ontario--(Newsfile Corp. - September
- CSE surpasses 800 listings for the first time -Toronto, Ontario--(Newsfile Corp. - September 13, 2022) - The Canadian Securities Exchange ("CSE" or "the Exchange") today announced its market statistics